Details of the Drug

General Information of Drug (ID: DMNELKW)

• Drug Name: GEN-011

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1	[1]
Non-small-cell lung cancer	2C25	Phase 1	[1]
Squamous head and neck cell carcinom	2D60.0	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DR1YQ7
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04596033) TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy. U.S. National Institutes of Health.